Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Behavioral Medicine

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1207/S15324796ABM3301_3PMID 17291167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cigarette smoking among adults--United States, 2006.

  2007cited by this paper
• Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling

  2007cited by this paper
• Cigarette Smoking Among Adults, United States

  2006cited by this paper
• Will Genetic Testing for Complex Diseases Increase Motivation to Quit Smoking? Anticipated Reactions in a Survey of Smokers

  2005cited by this paper
• American Thoracic Society/European Respiratory Society: Standards in Diagnostik und Therapie bei Patienten mit Alpha-1-Antitrypsin-Mangel

  2005cited by this paper
• Genetic testing for Alpha1-antitrypsin deficiency

  2004influential reference
• Nicotine dependence, quit attempts, and quitting among smokers in a regional population sample from a country with a high prevalence of tobacco smoking.

  2004cited by this paper
• Assessment of genetic testing and related counseling services: current research and future directions.

  2004cited by this paper
• Measures of abstinence in clinical trials: issues and recommendations.

  2003cited by this paper
• American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

  2003cited by this paper
• Genetic testing for lung cancer risk: if physicians can do it, should they?

  2002cited by this paper
• Genetic testing for lung cancer risk

  2002cited by this paper
• Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income.

  2002cited by this paper
• Biochemical verification of tobacco use and cessation.

  2002cited by this paper
• Genetic risk and behavioural change

  2001cited by this paper
• Susceptibility genes for rapid decline of lung function in the lung health study.

  2001cited by this paper
• Smoking cessation and smoking patterns in the general population: a 1-year follow-up.

  2001cited by this paper
• Interest in genetic testing among first-degree relatives of colorectal cancer patients.

  2000cited by this paper
• Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency.

  2000cited by this paper
• Occupational Exposure Risks in Individuals with PI*Z α1-Antitrypsin Deficiency

  2000cited by this paper
• Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial.

  1997cited by this paper
• Predictors of smoking cessation in a cohort of adult smokers followed for five years.

  1997cited by this paper
• Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change.

  1997influential reference
• Addiction versus stages of change models in predicting smoking cessation.

  1996cited by this paper
• Primary prevention in a high‐risk group: smoking habits in adolescents with homozygous alpha‐1‐antitrypsin deficiency (ATD)

  1996cited by this paper
• The transtheoretical model and stages of change.

  1996cited by this paper
• Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

  1995cited by this paper
• Attitudes about genetic testing for breast-ovarian cancer susceptibility.

  1994cited by this paper
• Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey.

  1994cited by this paper
• Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

  1994cited by this paper
• Host factors in lung cancer risk: a review of interdisciplinary studies.

  1992cited by this paper
• In Search of How People Change: Applications to Addictive Behaviors

  1992cited by this paper
• Family study of α1‐antitrypsin deficiency: Effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits

  1992cited by this paper
• Assessing outcome in smoking cessation studies.

  1992cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Tracking and attrition in longitudinal school-based smoking prevention research.

  1989cited by this paper
• The distribution of debrisoquine metabolic phenotypes and implications for the suggested association with lung cancer risk

  1989cited by this paper
• Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

  1989cited by this paper
• The Health Belief Model: A Decade Later

  1984cited by this paper

• α1-Antitrypsin Gene Variation Associates with Asthma Exacerbations and Related Health Care Utilization.

  2025cites this paper
• Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-world Data.

  2024cites this paper
• EASL Clinical Practice Guidelines on genetic cholestatic liver diseases.

  2024cites this paper
• Update Alpha-1-Antitrypsin-Mangel

  2024cites this paper
• Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye

  2024cites this paper
• Alpha-1 Antitrypsin Deficiency and Smoking Cessation: Tackling the Burden of COPD One Test at a Time?

  2023cites this paper
• Precision Approaches to Chronic Obstructive Pulmonary Disease Management.

  2023cites this paper
• Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease.

  2023cites this paper
• A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency

  2023influential citation
• Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential

  2023cites this paper
• Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency.

  2023cites this paper
• Development of a risk score to increase detection of severe alpha-1 antitrypsin deficiency

  2023cites this paper
• Exacerbations in Chronic Obstructive Pulmonary Disease: Clinical, Genetic and Mycobiome Risk Factors.

  2023cites this paper
• Interaction between Smoking and Genetic Risk of FEV1/FVC Ratio in Chronic Lung Disease: A Cross-Sectional Study

  2023cites this paper
• Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity

  2023cites this paper
• [Alpha 1-antitrypsin deficiency].

  2022cites this paper
• Influence of Psychological Factors on College Students' Smoking Behavior: Moderating Role of Tobacco Advertising Receptivity and Health Behavior.

  2022cites this paper
• Disease progression in patients with PI*ZZ alpha-1 antitrypsin deficiency

  2022cites this paper
• Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge

  2022cites this paper
• The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening

  2022cites this paper
• [French clinical practice guidelines for the diagnosis and management of lung disease with alpha 1-antitrypsin deficiency].

  2022cites this paper
• A polygenic risk score and age of diagnosis of COPD

  2022cites this paper
• Déficit en alpha-1 antitrypsine

  2022cites this paper
• Prevalence of Alpha-1 Antitrypsin Deficiency, Self-reported Behavior Change, and Healthcare Engagement Among Direct-to-Consumer Recipients of a Personalized Genetic Risk Report.

  2021cites this paper
• Genetic Factors Associated with COPD Depend on the Ancestral Caucasian/Amerindian Component in the Mexican Population

  2021cites this paper
• Information Avoidance, Self-affirmation, and Intentions to Receive Genomic Sequencing Results Among Members of an African Descent Cohort.

  2021cites this paper
• Associations of genetic risk and smoking with incident COPD

  2021cites this paper
• Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function

  2021cites this paper
• Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold

  2021cites this paper
• COPD_A_263297 2389..2397

  2020cites this paper
• Alpha-1 Antitrypsin Deficiency Associated COPD.

  2020cites this paper
• Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts

  2020cites this paper
• Alpha-1 Antitrypsin Deficiency and Tobacco Smoking: Exploring Risk Factors and Smoking Cessation in a Registry Population

  2020cites this paper
• Detection of alpha-1 antitrypsin deficiency: the past, present and future

  2020cites this paper
• Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US

  2020cites this paper
• Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.

  2019cites this paper
• What Motivates Individuals to Get Obesity Related Direct-To-Consumer Genetic Tests? A Reasoned Action Approach

  2019cites this paper
• Comparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet's Disease Management Program.

  2018cites this paper
• Genetic Testing for Alpha-1 Antitrypsin Deficiency Effective : July 1 , 2018

  2018influential citation
• A Systematic Review of Genetic Testing and Lifestyle Behaviour Change: Are We Using High-Quality Genetic Interventions and Considering Behaviour Change Theory?

  2018cites this paper
• Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease.

  2018cites this paper
• Actualización del algoritmo de diagnóstico de laboratorio del déficit de alfa-1-antitripsina : incorporación de la detección genotípica de la variante deficitaria Mmalton y utilización de muestras alternativas a la sangre total

  2017cites this paper
• One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States

  2017cites this paper
• Genetic Testing for Alpha-1 Antitrypsin Deficiency

  2017cites this paper
• Public health and precision medicine share a goal

  2017cites this paper
• Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult

  2016cites this paper
• WHAT COUNTS? THE ROLE OF NUMERACY IN INTERPRETATION OF PERSONALIZED GENOMIC RISK INFORMATION IN CORIELL PARTICIPANTS

  2016cites this paper
• The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

  2016cites this paper
• The Media and Behavioral Genetics

  2015influential citation
• Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research

  2015cites this paper
• Increasing Knowledge About Alpha-1 Antitrypsin Deficiency in the Chronic Obstructive Pulmonary Disease Population

  2015cites this paper
• Unwarranted Optimism in Media Portrayals of Genetic Research on Addiction Overshadows Critical Ethical and Social Concerns

  2015cites this paper
• A comparative effectiveness analysis of treatment for latent tuberculosis infection using multilevel selection models.

  2015cites this paper
• Health-Related Quality of Life in Patients with Alpha-1 Antitrypsin Deficiency: The French Experience

  2015cites this paper
• Le déficit en alpha-1 antitrypsine : avancées des connaissances et questions restantes

  2014cites this paper
• Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

  2014cites this paper
• Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency

  2014cites this paper
• The promise of using personalized genomic information to promote behavior change: is the debate over, or just beginning?

  2014cites this paper
• Alpha-1 Antitrypsin Deficiency — A Missed Opportunity in COPD?

  2014cites this paper
• Tabakentwöhnung bei COPD S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Smoking Cessation in Patients with COPD S3-Guideline issued by the German Respiratory Society

  2014cites this paper
• Effects of Patient Self-Selection on Costs to Treat Latent Tuberculosis Infection (LTBI)

  2014cites this paper
• An examination of the relationships between causal attributions for smoking and smokers' treatment seeking and quit intentions: A structural equation modeling approach

  2014influential citation
• Tabakentwöhnung bei COPD

  2014cites this paper
• Direct-to-consumer genetic testing

  2013cites this paper
• Public Health Genomics : translation of genomic research on smoking behaviour into evidence synthesis and guidelines for public health

  2013cites this paper
• Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.

  2013cites this paper
• Distinguishing alpha1-antitrypsin deficiency from asthma.

  2013cites this paper
• “Is it Really Worth it to Get Tested?”: Primary Care Patients’ Impressions of Predictive SNP Testing for Colon Cancer

  2013cites this paper
• Direct-to-consumer genetic testing.

  2012cites this paper
• Foreword: The Neuroethics of Drug Addiction

  2012cites this paper
• Addiction Neuroscience and Tobacco Control

  2012cites this paper
• Technical, Ethical and Social Issues in the Bioprediction of Addiction Liability and Treatment Response

  2012cites this paper
• Conference on ‘ Translating nutrition : integrating research , practice and policy ’ Symposium 4 : Diet and ageing Impact of genetic risk assessment on nutrition-related lifestyle behaviours

  2012cites this paper
• A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19 q 13

  2012cites this paper
• Impact of Genetic Notification on Smoking Cessation: Systematic Review and Pooled-Analysis

  2012cites this paper
• Serum levels and genotype distribution of α1-antitrypsin in the general population

  2012cites this paper
• Alpha-1 Antitrypsin Deficiency – A Genetic Risk Factor for COPD

  2012cites this paper
• Can genetic risk information for age-related macular degeneration influence motivation to stop smoking? A pilot study

  2012cites this paper
• Childhood obesity prevention in rural settings: background, rationale, and study design of ‘4-Health,’ a parent-only intervention

  2012cites this paper
• A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.

  2012cites this paper
• Integration of genomics into clinical care : methods for economic evaluation

  2012cites this paper
• When Do People Deploy Genetic Determinism? A Review Pointing to the Need for Multi-factorial Theories of Public Utilization of Scientific Discourses

  2011cites this paper
• Genome-Based Health Literacy: A New Challenge for Public Health Genomics

  2011cites this paper
• Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach

  2011cites this paper
• Informed Consent Process in Alpha-1 Testing of At-Risk Children: Views of Parents and Adults Tested as Children

  2011cites this paper
• Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis

  2011cites this paper
• How the genetics of lung cancer may overlap with COPD

  2011cites this paper
• Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease

  2011cites this paper
• Young smokers’ views of genetic susceptibility testing for lung cancer risk: minding unintended consequences

  2011cites this paper
• Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences.

  2011cites this paper
• Integrating Genetic Studies of Nicotine Addiction into Public Health Practice: Stakeholder Views on Challenges, Barriers and Opportunities

  2011cites this paper
• Personalized Medicine and Tobacco-Related Health Disparities: Is There a Role for Genetics?

  2011cites this paper
• Evaluation of a Brief Web-Based Genetic Feedback Intervention for Reducing Alcohol-Related Health Risks Associated with ALDH2

  2010cites this paper
• Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers

  2010cites this paper
• Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

  2010cites this paper
• Smoking cessation: the potential role of risk assessment tools as motivational triggers

  2010cites this paper
• Communicating Genetic and Genomic Information: Health Literacy and Numeracy Considerations

  2010cites this paper
• Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?

  2010cites this paper
• Future health applications of genomics: priorities for communication, behavioral, and social sciences research.

  2010cites this paper
• The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?

  2010cites this paper